NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
- Review Discovery of a potent, selective and orally active in vivo mGlu(4) positive allosteric modulator.[Probe Reports from the NIH Mol...]Review Discovery of a potent, selective and orally active in vivo mGlu(4) positive allosteric modulator.Hopkins CR, Engers DW, Niswender CM, Jones CK, Dawson E, Weaver CD, Daniels JS, Conn PJ, Lindsley CW. Probe Reports from the NIH Molecular Libraries Program. 2010
- The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.[J Pharmacol Exp Ther. 2012]The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.Jones CK, Bubser M, Thompson AD, Dickerson JW, Turle-Lorenzo N, Amalric M, Blobaum AL, Bridges TM, Morrison RD, Jadhav S, et al. J Pharmacol Exp Ther. 2012 Feb; 340(2):404-21. Epub 2011 Nov 16.
- Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia.[Neuropharmacology. 2013]Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia.Bennouar KE, Uberti MA, Melon C, Bacolod MD, Jimenez HN, Cajina M, Kerkerian-Le Goff L, Doller D, Gubellini P. Neuropharmacology. 2013 Mar; 66:158-69. Epub 2012 Apr 3.
- Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers.[ACS Chem Neurosci. 2016]Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers.Niswender CM, Jones CK, Lin X, Bubser M, Thompson Gray A, Blobaum AL, Engers DW, Rodriguez AL, Loch MT, Daniels JS, et al. ACS Chem Neurosci. 2016 Sep 21; 7(9):1201-11. Epub 2016 Aug 5.
- Review Discovery of a potent, selective and in vivo active mGluR4 positive allosteric modulator.[Probe Reports from the NIH Mol...]Review Discovery of a potent, selective and in vivo active mGluR4 positive allosteric modulator.Hopkins CR, Niswender CM, Lewis LM, Weaver CD, Lindsley CW. Probe Reports from the NIH Molecular Libraries Program. 2010
- Table 1, Stability of ML292 - Probe Reports from the NIH Molecular Libraries Pro...Table 1, Stability of ML292 - Probe Reports from the NIH Molecular Libraries Program
- Rattus norvegicus receptor-like tyrosine kinase (Ryk), mRNARattus norvegicus receptor-like tyrosine kinase (Ryk), mRNAgi|61097925|ref|NM_080402.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...